Michael Hasenauer is Strategic Account Manager & Principal Advisor at Körber Pharma Software since February 2022, developing and implementing global strategies for strategic accounts within the Pharma-, Biotech and Cell & Gene industry.

Körber Pharma Software (previously Werum) is the market leader in Manufacturing Execution Systems / MES Solutions for the Life Science industries, working for 17 out of the Global Top 30 Pharma Companies with more than 800 installations.

Michael has 15 years of experience in various digitalization and digital transformation roles in the medical device and pharmaceutical industry. The past 8 years he was working for Novartis in different roles with increasing responsibility on a local and global level. He was responsible for the MES business project management and digitalization journey for the Schaftenau Drug Product site in Austria as well as for the harmonization and standardization of Sterile Manufacturing and Packaging Processes within the global Aseptics network. In his most recent role he was the Digital Product Owner for a global digital lighthouse program to build an Insights Center based on advanced analytics ecosystem and user centric digital solutions, e.g. to empower the manufacturing sites with advanced analytics for tactical decision making in real time or the simulation of economic order quantity for optimizing supply chain and manufacturing costs.

Körber is an international technology group with around 10,000 employees and more than 100 locations worldwide. At the Business Area Pharma we deliver the difference along the entire pharmaceutical value chain by offering a unique portfolio of integrated solutions. Based on in-depth experience spanning consulting, inspection, transport systems, packaging machines and materials, track and trace and software, we understand the challenges in pharmaceutical processes and regulation that our customers face day to day, from the beginning to the end of their production. For them, we deliver the difference to unlock the potential of global pharmaceutical and biotech manufacturing.